ABSTRACT OF THE WEEK

Journal of veterinary internal medicine/ American College of Veterinary Internal Medicine
Volume 35 | Issue 4 (July 2021)

Daytime and nocturnal activity in treated dogs with idiopathic epilepsy compared to matched unaffected controls.

J Vet Intern Med. July 2021;35(4):1826-1833.

Megan Barry¹, Starr Cameron², Sean Kent³, Heidi Barnes Heller⁴, Kylie Grady⁵

¹ Department of Medical Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.; ² Department of Medical Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.; ³ Department of Statistics, University of Wisconsin-Madison, Madison, Wisconsin, USA.; ⁴ Barnes Veterinary Specialty Service, Madison, Wisconsin, USA.; ⁵ Department of Medical Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Abstract

BACKGROUND:In dogs, antiepileptic drugs (AED) cause lethargy but quantitative data regarding the effects of AED on activity levels are not available, and little is known about how AEDs affect sleep quality.

OBJECTIVE:To quantitatively compare activity levels and nocturnal activity in dogs previously diagnosed with idiopathic epilepsy (IE) receiving AEDs compared to age- and breed-matched control dogs.

ANIMALS:Sixty-two dogs with IE and 310 control dogs.

METHODS:This is a 3-month prospective parallel observational study. An activity monitoring device for dogs was used to measure daily activity levels and sleep scores in all dogs.

RESULTS:Dogs with IE treated with AEDs had an 18% average lower baseline activity level compared to control dogs (P = .005; point estimate = 0.82, 95% confidence interval [CI], 0.75-0.90). The combination of phenobarbital and potassium bromide (KBr) was associated with an average 28% decrease in activity in dogs with IE compared to control dogs (P = .03; point estimate = 0.72; CI, 0.62-0.82). Mean sleep scores were not significantly different in dogs with IE receiving AEDs compared to control dogs (P = .43). However, higher dosages of KBr were associated with lower sleep scores (P = .01).

CONCLUSIONS:Dogs with IE receiving AEDs have lower activity levels, but no difference in sleep scores, compared to controls. The combination of phenobarbital and KBr had the largest decrease in activity between groups. Higher doses of KBr may affect nocturnal activity in epileptic dogs.

Keywords

antiepileptic drugs; canine activity monitoring device;

Article Tools:

Medline

Email to me

Grants:

233 AAG5571 872100 4 University of Wisconsin - Madison, School of Veterinary Medicine, Companion Animal Fund

Archives Highlights:

Left hind limb lameness in a 13-month-old spayed female German Shepherd Dog.
This case report discusses medial epiphyseal artery occlusion that resulted in osteonecrosis and collapse of the femoral head.

"Do Your Homework as Your Heart Takes over When You Go Looking": Factors Associated with Pre-Acquisition Information-Seeking among Prospective UK Dog Owners.
Of potential owners, 68% reported already having looked for information, while a further 14% were planning to undertake research prior to acquiring a dog. Those with previous dog ownership experience were less likely to undertake pre-acquisition research, as were those who had worked with dogs. Among current owners, pre-acquisition research was more likely among those who acquired their dog through a breeder; a specific breed or a mix of two breeds; or as a puppy.

Equine Gunshot Euthanasia: Creation of a 3D-Printed Model with Integrated Sensors for Training.
Here, we report the development and production of a portable, reusable, equine gunshot euthanasia training model. The model facilitates the training of veterinary personnel and first responders in successful gunshot euthanasia, providing instantaneous feedback on the likelihood of a shot causing immediate, humane death in a live animal.

'Brave Enough': A Qualitative Study of Veterinary Decisions to Withhold or Delay Antimicrobial Treatment in Pets.
The use of antimicrobials by companion animal veterinarians in the absence of a clear indication is often powerfully driven by behavioural beliefs, chiefly, fears of clinical deterioration and of failing to meet client expectations.

Dimethyl sulfoxide favors the emetic efficacy of lycorine in beagle dogs - a novel strategy for the treatment of poisoning.
By emesis response analysis four dimethyl sulfoxide (DMSO)-based active pharmaceutical ingredient (API) formulations were favored. Two of them (lycorine hydrochloride, 15 mg/mL in 70% DMSO, 10% ethanol, and 20% water; and lycorine hydrochloride, 15 mg/mL in 50% DMSO, 50% water) qualified for further drug development. Both formulations ensure a safe pharmacologically induced emesis within about 30 min after injection, suitable for use as an in time decontaminant in acute poisoning of dogs. DMSO-based formulations were well tolerated and offer a novel promising strategy for treatment of poisoning.